Can a lean, insulin-sensitive phenotype show high LDL, high HDL, and low triglycerides?

A lean, insulin-sensitive phenotype can present with a highly specific lipid triad of elevated low-density lipoprotein cholesterol (LDL-C), elevated high-density lipoprotein cholesterol (HDL-C), and low triglycerides. Often termed the lean mass hyper-responder (LMHR) phenotype, this profile represents a benign metabolic adaptation rather than classic metabolic dysfunction.

Clinical and metabolic distinction

• Classic insulin resistance is characterized by an atherogenic dyslipidemia consisting of high triglycerides and low HDL-C.
• Conversely, the LMHR phenotype is characterized by exceptionally low triglycerides and high HDL-C in individuals with high insulin sensitivity, demonstrating a biologically distinct profile.

Mechanistic lipid trafficking

• Under carbohydrate-restricted or ketogenic diets, a systemic shift toward fat oxidation occurs to meet the body’s energy demands, a framework described by the lipid energy model.
• To support this shift, the body upregulates systemic lipid trafficking, mobilizing fat-derived fuels via triglyceride-rich lipoproteins.
• Rapid turnover and clearance of these triglycerides leave behind elevated levels of circulating LDL-C, while simultaneously increasing HDL-C.

Safety and cardiovascular considerations

• Although this lipid triad reflects efficient fuel trafficking rather than insulin resistance, extreme elevations in circulating LDL-C may still drive atherosclerotic plaque progression.
• A favorable metabolic profile and high insulin sensitivity do not fully eliminate the atherogenic potential of high circulating apoB-containing particles.

Bottom line

• This lipid profile is an adaptive response to carbohydrate restriction driven by systemic lipid trafficking rather than insulin resistance; however, because markedly elevated LDL-C may still promote arterial plaque accumulation, overall cardiovascular risk should be carefully and individually managed.